top of page
16 Annual
National Pharmaceutical Congress
Ben Parry
Pangaea Consultants
Panel 1: The Future of Rare Disease
and Oncology
Sean McBride
Bayshore Specialty Rx
Sandra Heller
Seagen Canada
Pat Forsythe
Eisai Inc.
Ryan Lock
GSK
Panel 1 Q&A
Panel 2: Omni-Channel Marketing
Dave Cann
Ashfield Engage
Leandra Wells
GSK
Andrea Schwarz
BeiGene
Tamer Yacoub Hanna
GSK
Panel 2 Q&A
​
Panel 3: Unlocking Engagement in a Changing World
Stephanie Babbit
McKesson Canada
Janine Pajot, David Renwick, Carol Stiff
Bayer, Emergent Biosolutions, Rhythm Pharmaceuticals (resp.)
Panel 4: Evolving Roles in Commercial & Medical
Tiana DiMichele
Impres
Robin Hunter
Tolmar
Kevin Leshuk
Forus Therapeutics
Bob McLay
Sobi Canada Inc.
Panel 4 Q&A
Panel 5: Pharma's New Role in the LifeSci Ecosystem
Jessica Lovett
Innomar Strategies
Ross Glover
Taiho Pharma
Christine Lennon
Incyte Biosciences
Andrew Casey
BIOTECanada
Panel 5 Q&A
Keynote: The State of Life Sciences Investment in 2022
Brian Bloom
Bloom Burton & Co
Diverse Voices
Aliya Therani
Shoppers Drug Mart
Dr. Kwadwo Kyeremanteng
The Ottawa Hospital
Zal Press
CADTH
Danielle Portnik
Ambry Genetics
Niki Papaioannou
Niki Inc.
Angelina Braithwaite
Brunel Canada
Peter Brenders
BeiGene
Diverse Voices Q&A
bottom of page